Prospective cohort study on novel blood markers in hepatocellular carcinoma

Prospective cohort study on novel blood markers in hepatocellular carcinoma - Prospective cohort study on novel blood markers in hepatocellular carcinoma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000031562

Enrollment

300

Registered

2018-03-05

Start date

2017-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with diagnosed hepatocellular carcinoma by blood collection and imaging studies.

Exclusion criteria

Exclusion criteria: 1) Persons judged inappropriate for this study

Design outcomes

Primary

Measure	Time frame
To elucidate the blood marker in diagnosis of hepatocellular carcinoma by proteomics analysis, metabolomics analysis, and miRNA analysis using serum and plasma of patients with hepatocellular carcinoma.	—

Secondary

Measure	Time frame
1) To elucidate the blood marker in diagnosis of hepatocellular carcinoma by individual protein expression analysis and individual miRNA analysis using serum and plasma of patients with hepatocellular carcinoma. 2) Abdominal skeletal muscle mass analysis using CT/MRI image at diagnosis of hepatocellular carcinoma	—

Countries

Japan

Contacts

Public ContactYuji Ogawa

Yokohama City University School of Medicine Department of Gastroenterology and Hepatology

ogaway@yokohama-cu.ac.jp045-787-2640

Outcome results